Death possibly associated with interferon use in a patient with chronic hepatitis [5]

Acta Paediatrica, International Journal of Paediatrics

Volumn 94, Issue 7, 2005, Pages 984-985

  Kendirli, Tanil ^a   Kismet, Erol ^a   Demirkaya, Erkan ^a   Aydin, Halil Ibrahim ^a   Kesik, Vural ^a   Köseoǧlu, Vedat ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2A INTERFERON; CEFTRIAXONE; DOBUTAMINE; DOPAMINE;

ANAPHYLACTIC SHOCK; CASE REPORT; CHILL; CHRONIC HEPATITIS; CYTOTOXICITY; DOSE RESPONSE; FATALITY; FATIGUE; FEMALE; FEVER; HUMAN; LETTER; MALAISE; NAUSEA; PRESCHOOL CHILD; PRIORITY JOURNAL; SEPTIC SHOCK; VOMITING;

ANAPHYLAXIS; ANTIVIRAL AGENTS; CHILD, PRESCHOOL; FATAL OUTCOME; FEMALE; HEPATITIS B, CHRONIC; HUMANS; INTERFERON ALFA-2A;

EID: 22944455547     PISSN: 08035253     EISSN: None     Source Type: Journal    
DOI: 10.1080/08035250510028371     Document Type: Letter

References (8)

1. Okanoue T, Sakamoto S, Itoh Y, Minami M, Yasui K, Sakamoto M, et al. Side effects of high-dose interferon therapy for chronic hepatitis C. J Hepatol 1996;25:283-91.
2. Baluna R, Vitetta ES. Vascular leak syndrome: a side effect of immunotherapy. Immunopharmacol 1997;37:117-32.
3. Kansu A, Altuntaş B, Doǧanci T, Kalayci AG, Girgin N. The efficacy and side effects of interferon alpha 2a (Roferon) on chronic virus infection in Turkish children. Hepatol Res 1999;15:1-9.
4. Fontana RJ. Neuropsychiatric toxicity of antiviral treatment in chronic hepatitis C. Dig Dis 2000;18:107-16.
5. Trask PC, Esper P, Riba M, Redman B. Psychiatric side effects of interferon therapy: prevalence, proposed mechanisms, and future directions. J Clin Oncol 2000;18:2316-26.
6. Ballauff A, Schneider T, Gerner P, Habermehl P, Behrens R, Wirth S. Safety and efficacy of interferon retreatment in children with chronic hepatitis B. Eur J Pediatr 1998;157:382-5.
7. Beckman DB, Mathisen TL, Harris KE, Boxer MB, Grammer LC. Hypersensitivity to IFN-alpha. Allergy 2001;56:806-7.
8. Fattovich G, Giustina G, Favarato S, Ruol A. A survey of adverse events in 11,241 patients with chronic viral hepatitis treated with alfa interferon. J Hepatol 1996;24:38-47.